MarketPulse

GERD

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Phathom Pharmaceuticals, Inc.

Phathom's VOQUEZNA Posts 104% Revenue Growth Ahead of DDW 2026 Showcase

Phathom Pharmaceuticals reports Q1 2026 revenues of $58.3M, up 104% YoY, as VOQUEZNA reaches 1.35M prescriptions. Company to present clinical data at Digestive Disease Week.
PHATrevenue growthGERD
BenzingaBenzinga··Prnewswire

Lucid Diagnostics Plans Q4 2025 Earnings Call for March 26

Lucid Diagnostics ($LUCD) schedules Q4 2025 earnings call for March 26, 2026, with CEO and CFO discussing financial results and growth strategy.
LUCDPAVMearnings callcancer prevention